
RYVER.AI provides synthetic radiology images with annotations to help medical AI teams reduce time and cost in data acquisition. Their platform utilizes generative models that can be fine-tuned with user data, allowing for the generation of high-quality synthetic images. RYVER aims to improve the accuracy and robustness of AI models by increasing data diversity and enabling oversampling of underrepresented subgroups. The company offers significant cost savings (80-90% per image) and faster development cycles by substituting traditional data acquisition and annotation efforts. Their technology integrates easily into data pipelines, offering a graphical interface for discovery and a Python library for generation and assessment of synthetic data, including utility evaluation and downstream performance analysis.

RYVER.AI provides synthetic radiology images with annotations to help medical AI teams reduce time and cost in data acquisition. Their platform utilizes generative models that can be fine-tuned with user data, allowing for the generation of high-quality synthetic images. RYVER aims to improve the accuracy and robustness of AI models by increasing data diversity and enabling oversampling of underrepresented subgroups. The company offers significant cost savings (80-90% per image) and faster development cycles by substituting traditional data acquisition and annotation efforts. Their technology integrates easily into data pipelines, offering a graphical interface for discovery and a Python library for generation and assessment of synthetic data, including utility evaluation and downstream performance analysis.
What they do: Generate annotated synthetic radiology images and tooling to evaluate utility and privacy for medical AI teams
HQ: Munich, Germany
Team size: 5 employees
Funding: Approximately $1.4M total, latest pre-seed Dec 6, 2023
Synthetic medical imaging for AI model training, privacy-preserving data augmentation, and dataset diversity/quality evaluation.
2021
Healthcare AI; Medical imaging
“Bayern Kapital listed among investors”